Back to Browse Journals » Clinical Epidemiology » Volume 3 » Issue 1

Perfluoroalkyl chemicals and elevated serum uric acid in US adults

Authors Shankar A, Xiao J, Ducatman A

Published Date September 2011 Volume 2011:3(1) Pages 251—258


Published 30 September 2011

Anoop Shankar, Jie Xiao, Alan Ducatman
Department of Community Medicine, West Virginia University School of Medicine, Morgantown, WV, USA

Background: Perfluoroalkyl chemicals, including perfluorooctanoic acid and perfluorooctane sulfonate, are man-made chemicals that have been detected in the blood of over 98% of the US population. Serum uric acid is a novel biomarker, even mild elevations of which has been implicated in the development of hypertension, diabetes mellitus, cardiovascular disease, and chronic kidney disease. We examined the relationship of serum perfluoroalkyl chemicals, including perfluorooctanoic acid and perfluorooctane sulfonate, and elevated uric acid levels in a representative sample of US adults.
Methods: We examined 3883 participants from the 1999–2000 and 2003–2006 National Health and Nutritional Examination Surveys,
a representative, multiethnic population-based survey of noninstitutionalized US adults. Serum perfluorooctanoic acid and perfluorooctane sulfonate were analyzed as quartiles. The main outcome was hyperuricemia.
Results: We found that serum levels of perfluoroalkyl chemicals, including perfluorooctanoic acid and perfluorooctane sulfonate, were positively associated with hyperuricemia. This association appeared to be independent of confounders such as age, gender, race-ethnicity, body mass index, diabetes, hypertension, and serum cholesterol. Compared with subjects in quartile 1 (referent), the multivariate odds ratio for hyperuricemia among subjects in quartile 4 was 1.97
(95% confidence interval 1.44–2.70, P < 0.0001) for perfluorooctanoic acid and 1.48% (95% confidence interval
0.99–2.22, P = 0.0433) for perfluorooctane sulfonate. This observed association persisted in subgroup analysis by gender and body mass index.
Conclusion: Our results demonstrate that elevated levels of perfluoroalkyl chemicals are associated with hyperuricemia even at low perfluoroalkyl chemical exposure levels as seen in the US general population.

Keywords: perfluoroalkyl chemicals, perfluorooctanoic acid, perfluorooctane sulfonate, uric acid

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Other article by this author:

Estimating glomerular filtration rate in a population-based study

Anoop Shankar, Kristine E Lee, Barbara EK Klein, et al

Vascular Health and Risk Management 2010, 6:619-627

Published Date: 16 July 2010

Readers of this article also read:

Registration of acute medical hospital admissions in the Danish National Patient Registry: a validation study

Vest-Hansen B, Riis AH, Christiansen CF

Clinical Epidemiology 2013, 5:129-133

Published Date: 26 April 2013

Quality of life and baseline characteristics associated with depressive symptoms among patients with heart disease

Rejai S, Giardino ND, Krishnan S, Ockene IS, Rubenfire M, Jackson EA

Clinical Epidemiology 2012, 4:181-186

Published Date: 24 July 2012

Allopurinol causing drug rash with eosinophilia and systemic symptoms syndrome: a challenging diagnosis

Hassan S, Wetz R, Zouein E

International Journal of General Medicine 2011, 4:789-792

Published Date: 22 November 2011

Pancreatic cancer survival in central and northern Denmark from 1998 through 2009: a population-based cohort study

Cronin-Fenton DP, Erichsen R, Mortensen FV, Dikinis S, Nørgaard M, Jacobsen JB

Clinical Epidemiology 2011, 3:19-25

Published Date: 20 July 2011

Use of prescribed drugs among primiparous women: an 11-year population-based study in Denmark

Bjørn AM, Nørgaard M, Hundborg HH, Nohr EA, Ehrenstein V

Clinical Epidemiology 2011, 3:149-156

Published Date: 2 May 2011

Emerging role of rasburicase in the management of increased plasma uric acid levels in patients with hematologic malignancies

LeAnne D Kennedy, Susannah Koontz, Kamakshi Rao

Journal of Blood Medicine 2011, 2:1-6

Published Date: 4 February 2011

New and improved strategies for the treatment of gout

Natalie Dubchak, Gerald F Falasca

International Journal of Nephrology and Renovascular Disease 2010, 3:145-166

Published Date: 24 November 2010